TipRanks
Go Ultimate55% OFF

Polaryx Therapeutics, Inc. (PLYX) Financial Statements

Polaryx Therapeutics, Inc. Financial Overview

Polaryx Therapeutics, Inc.'s market cap is currently $87.23M. The company's EPS TTM is $-0.12; its P/E ratio is -14.38; Polaryx Therapeutics, Inc. has not announced its next earnings date. See an overview of income statement, balance sheet, and cash flow financials.

Financial overview
Dec 25Dec 24Dec 23
Income Statement
Total Revenue$ 0.00$ 0.00$ 0.00
Gross Profit$ 0.00$ 0.00$ 0.00
Operating Income$ -7.82M$ -4.35M$ -3.78M
EBITDA$ -8.98M$ -30.36M$ -3.78M
Net Income$ -8.98M$ -30.36M$ -3.78M
Balance Sheet
Cash & Short-Term Investments$ 5.14M$ 4.62M$ 2.00K
Total Assets$ 5.42M$ 5.00M$ 2.31M
Total Debt$ 0.00$ 0.00$ 128.00K
Net Debt$ -5.14M$ -4.62M$ 126.00K
Total Liabilities$ 855.00K$ 289.00K$ 1.04M
Stockholders' Equity$ 4.57M$ 4.71M$ 1.28M
Cash Flow
Free Cash Flow$ -3.94M$ -2.57M$ -173.00K
Operating Cash Flow$ -3.94M$ -2.57M$ -173.00K
Investing Cash Flow$ 0.00$ 0.00$ 0.00
Financing Cash Flow$ 4.47M$ 7.19M$ 128.00K

Currency in USD

Polaryx Therapeutics, Inc. Earnings and Revenue History

-36M-24M-12M00 %0.4 %0.8 %1.2 %EarningsProfit Margin202320242025RevenueEarningsProfit Margin

Polaryx Therapeutics, Inc. Debt to Assets

02M4M6M0 %20 %40 %60 %LiabilitiesDebt to Assets202320242025AssetsLiabilitiesDebt to Assets

Polaryx Therapeutics, Inc. Cash Flow

-5M-2.5M02.5M5M7.5M10M202320242025OperatingInvestingFinancing

Polaryx Therapeutics, Inc. Forecast EPS vs Actual EPS